JB Chemicals & Pharmaceuticals Balance Sheet Annual

Trade

BSE: 506943 | NSE: JBCHEPHARM | ISIN: INE572A01036 | Sector: Biotechnology & Drugs

1,741.60 -43.40 (-2.43%)Updated : 17 Jan 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	64.71	50.02	54.72	25.30
Cash Equivalents	23.50	26.91	1.82	3.39
Short Term Investments	371.42	192.27	1.21	668.92
Cashand Short Term Investments	459.64	269.20	57.75	697.61
Accounts Receivable- Trade Net	687.43	576.19	555.69	389.02
Total Receivables Net	860.19	794.84	755.73	484.89
Total Inventory	513.79	444.08	441.05	351.15
Prepaid Expenses	16.32	16.70	12.04	12.26
Other Current Assets Total	3.40	3.21	8.28	6.70
Total Current Assets	1,853.35	1,528.03	1,274.86	1,552.60
Property/ Plant/ Equipment Total- Gross	1,335.26	1,219.91	1,149.74	1,107.78
Accumulated Depreciation Total	-700.38	-643.49	-582.92	-538.12
Property/ Plant/ Equipment Total- Net	634.88	576.42	566.82	569.66
Goodwill Net	57.46	57.46	57.46	57.46
Intangibles Net	1,388.45	1,322.28	671.39	32.11
Long Term Investments	28.51	27.40	17.54	13.09
Note Receivable- Long Term	19.20	29.89	11.95	5.62
Other Long Term Assets Total	12.28	12.38	7.38	7.58
Total Assets	3,994.13	3,553.87	2,607.40	2,238.12
Accounts Payable	356.31	238.65	224.48	186.92
Accrued Expenses	0.00	0.03	0.01	0.00
Notes Payable/ Short Term Debt	15.34	28.02	0.00	6.21
Current Portof LT Debt/ Capital Leases	329.04	145.89	33.94	33.63
Other Currentliabilities Total	167.54	141.87	125.29	118.50
Total Current Liabilities	868.23	554.45	383.72	345.27
Long Term Debt	23.64	383.22	-	-
Capital Lease Obligations	9.64	15.32	20.62	5.14
Total Long Term Debt	33.28	398.54	20.62	5.14
Total Debt	377.66	572.45	54.56	44.99
Deferred Income Tax	149.21	102.82	47.56	56.77
Minority Interest	0.00	0.00	4.49	3.71
Other Liabilities Total	20.09	17.70	16.90	17.50
Total Liabilities	1,070.80	1,073.52	473.28	428.39
Common Stock Total	15.52	15.48	15.46	15.46
Additional Paid- In Capital	113.39	69.73	50.77	50.77
Retained Earnings( Accumulated Deficit)	2,808.94	2,398.76	2,058.17	1,737.60
Unrealized Gain( Loss)	0.35	0.35	0.35	0.35
Other Equity Total	-14.87	-3.97	9.38	5.55
Total Equity	2,923.33	2,480.35	2,134.12	1,809.72
Total Liabilities Shareholders' Equity	3,994.13	3,553.87	2,607.40	2,238.12
Total Common Shares Outstanding	15.52	15.48	15.46	15.46
Tangible Book Valueper Share Common Eq	95.20	71.12	90.92	111.29